ADCs Cytotoxin
Filter Criteria
By Category
By SubCategory
By Functional Group
By Formula Weight
Questions & Comments
Verification code

ADCs Cytotoxin

Filtered by
Clear All
Catalog Product Name CAS Number
BADC-00738 MA-PEG4-VA-PBD 1342820-68-1
MA-PEG4-VA-PBD is a drug-linker conjugate for ADC by using PBD (Pyrrolobenzodiazepine dimers, a potent antitumor antibiotic), linked via MA-PEG4-VA. Inquiry
BADC-00751 DBCO-PEG4-MMAF 2360411-65-8
DBCO-PEG4-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF,a potent tubulin polymerization inhibitor), linked via DBCO-PEG4. Inquiry
BADC-00771 Thailanstatin B
a Pre-mRNA splicing inhibitor. Thailanstatin B is used as a cytotoxin for ADCs. Inquiry
BADC-00772 Thailanstatin C
a Pre-mRNA splicing inhibitor. Thailanstatin C is used as a cytotoxin for ADCs. Inquiry
BADC-00773 Thailanstatin D
a Pre-mRNA splicing inhibitor. The direct precursor of Thailanstatin A. Thailanstatin D is used as a cytotoxin for ADCs. Inquiry
BADC-00774 Fr901463
a potent cell cycle inhibitor. Fr901463 exhibited potent antitumor activities against tumor cell lines via binding to the spliceosome and modulating pre-mRNA splicing. Inquiry
BADC-00777 Meayamycin
a potent pre-mRNA splicing inhibitor. Meayamycin modulates or inhibits splicing by targeting SF3B1. Inquiry
BADC-00778 Pladienolide B 445493-23-2
a potent pre-mRNA splicing inhibitor. Pladienolide B has shown strong inhibitory effect against activity and growth of various cell lines via targeting SF3b. Inquiry
BADC-00779 Pladienolide D
a potent pre-mRNA splicing inhibitor. Pladienolide D has shown strong antitumor activity via targeting SF3b. Inquiry
BADC-00781 Spliceostatin B
a potent pre-mRNA splicing inhibitor. Spliceostatin B, an analog of FR901464, shows a weaker cytotoxic effect in cancer cells than FR901464. Inquiry
BADC-00782 Spliceostatin C
a potent pre-mRNA splicing inhibitor. Spliceostatin C is an analog of the natural product FR901464 and has shown a potent inhibit activity of eukaryotic RNA splicing via binding to SF3b. Inquiry
BADC-00783 Sudemycin C
a potent pre-mRNA splicing inhibitor. Sudemycin C has a potent inhibit activity of eukaryotic RNA splicing via binding to SF3b. Inquiry
BADC-00785 Sudemycin E 1197054-49-1
a potent pre-mRNA splicing inhibitor. Sudemycin E is an analog of the natural product FR901464 and show a potent inhibit activity of cancer cell lines. Inquiry
BADC-00786 Sudemycin E0
a potent pre-mRNA splicing inhibitor. Sudemycin E0 is an analog of the natural product FR901464 and shows a potent inhibit activity of cancer cell lines. Inquiry
BADC-00787 Sudemycin F1
a potent pre-mRNA splicing inhibitor. Sudemycin F1 is an analog of the natural product FR901464 and shows a potent inhibit activity of cancer cell lines. Inquiry
BADC-00792 Illudin M 1146-04-9
Illudin M is a natural sesquiterpene agent with strong anti-tumour activity. Inquiry
BADC-00793 PDM3
20-O-Deme-thylansamitocin P-3 (PDM3),an ansamacrolide and maytansine analogue, has a greater antitumor activities against P388 and L 1210 than AP3. Inquiry
BADC-00794 Esperamicin
Esperamicinis an antitumor antibiotics, which combines the structural features of the anthracyclines and the enediynes. Esperamicinis are extremely toxic DNA splicing compounds and exhibits highly potent antitumor activity. Inquiry
BADC-00795 Anthramcyin
Anthramycin is a class of Pyrrolobenzodiazepines (PBDs)that shows antibacterial and potent antitumor activity. Anthramycin works by selectively inhibiting the synthesis of RNA and DNA of carcinoma cells. Inquiry
BADC-00796 Sibiromycin 12684-33-2
It is an aminoglycoside antibiotic produced by the strain of Streptosporangium sibiricum. It has anti-bacterial effect and has an inhibitory effect on reticuloendothelial sarcoma RAB-1 and oncogenic AK/LY cells. Two times of the maximum tolerated dose of intravenous administration can inhibit OZH-5 tumor and lymphosarcoma Lic-1. It has very high DNA binding affinity and cytotoxicity against cancer cell lines. Inquiry
Inquiry Basket